Mrinal P Dutia, MD
Hematology/Oncology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: 051589. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dutia’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A92209 · Current
Licensed to practise in California · since 2005 · expires 2026-12-31 · University of Mumbai, Grant Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$2,894,364
Pharmacies billed $2,894,364 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (25 of 891) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.
680 generic and 211 brand-name prescriptions · $2,894,364 in drug cost · 44 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lenalidomide | 79 | $878,258 | $11,117 |
| Brukinsa | 58 | $506,472 | $8,732 |
| Pomalyst | 15 | $348,661 | $23,244 |
| Venclexta | 25 | $286,068 | $11,443 |
| Tasigna | 13 | $64,987 | $4,999 |
See all 21 drugs
| Lenalidomide | 79 | $878,258 | $11,117 |
| Brukinsa | 58 | $506,472 | $8,732 |
| Pomalyst | 15 | $348,661 | $23,244 |
| Venclexta | 25 | $286,068 | $11,443 |
| Tasigna | 13 | $64,987 | $4,999 |
| Bosulif | 17 | $57,529 | $3,384 |
| Atovaquone | 12 | $3,559 | $297 |
| Hydroxyurea | 65 | $3,227 | $50 |
| Acyclovir | 72 | $2,605 | $36 |
| Anastrozole | 36 | $1,027 | $29 |
| Entecavir | 23 | $775 | $34 |
| Potassium Chloride | 16 | $706 | $44 |
| Dexamethasone | 20 | $504 | $25 |
| Gabapentin | 15 | $329 | $22 |
| Famotidine | 24 | $237 | $10 |
| Pantoprazole | 20 | $226 | $11 |
| Hydrocodone-Acetaminophen | 16 | $210 | $13 |
| Ondansetron | 25 | $201 | $8 |
| Allopurinol | 20 | $185 | $9 |
| Prednisone | 14 | $153 | $11 |
| Sulfamethoxazole-Trimethoprim | 13 | $150 | $12 |
Year by year
| 2024 | 891 | 145 | 3% (25) | 24% | $2,894,364 |
| 2023 | 966 | 153 | 6% (58) | None | $2,966,888 |
| 2022 | 919 | 171 | 2% (20) | None | $2,513,811 |
| 2021 | 817 | 149 | 4% (30) | 30% | $2,506,133 |
| 2020 | 634 | 133 | 6% (36) | 27% | $1,586,028 |
| 2019 | 657 | 128 | 8% (52) | None | $1,234,895 |
| 2018 | 624 | 127 | 7% (41) | None | $1,167,272 |
| 2017 | 581 | 118 | 5% (26) | None | $1,026,797 |
| 2016 | 550 | 103 | 15% (81) | None | $752,302 |
| 2015 | 485 | 100 | 15% (74) | 17% | $146,433 |
| 2014 | 774 | 76 | 8% (62) | 22% | $846,813 |
| 2013 | 548 | 58 | 8% (41) | 21% | $466,567 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Lenalidomide | 94 | $1,078,616 | $11,475 |
| Pomalyst | 16 | $363,678 | $22,730 |
| Brukinsa | 41 | $333,889 | $8,144 |
| Ibrance | 20 | $279,454 | $13,973 |
| Jakafi | 17 | $245,923 | $14,466 |
| Ninlaro | 14 | $176,694 | $12,621 |
| Venclexta | 29 | $174,584 | $6,020 |
| Tasigna | 13 | $60,258 | $4,635 |
| Hydroxyurea | 70 | $3,349 | $48 |
| Acyclovir | 71 | $2,923 | $41 |
| Anastrozole | 52 | $1,361 | $26 |
| Entecavir | 18 | $829 | $46 |
| Dexamethasone | 20 | $697 | $35 |
| Potassium Chloride | 15 | $669 | $45 |
| Hydrocodone-Acetaminophen | 42 | $479 | $11 |
| Famotidine | 37 | $397 | $11 |
| Gabapentin | 17 | $336 | $20 |
| Ondansetron | 25 | $222 | $9 |
| Prochlorperazine Maleate | 12 | $205 | $17 |
| Allopurinol | 20 | $177 | $9 |
| Furosemide | 13 | $166 | $13 |
| Prednisone | 13 | $160 | $12 |
| Pantoprazole | 13 | $113 | $9 |
| Sulfamethoxazole-Trimethoprim | 11 | $89 | $8 |
2022: 22 drugs
| Revlimid | 43 | $704,576 | $16,385 |
| Lenalidomide | 24 | $284,004 | $11,833 |
| Jakafi | 19 | $280,814 | $14,780 |
| Ibrance | 20 | $262,524 | $13,126 |
| Venclexta | 29 | $197,696 | $6,817 |
| Ninlaro | 13 | $191,033 | $14,695 |
| Entecavir | 19 | $3,903 | $205 |
| Acyclovir | 68 | $3,455 | $51 |
| Hydroxyurea | 56 | $3,276 | $59 |
| Anastrozole | 65 | $1,690 | $26 |
| Dexamethasone | 26 | $1,632 | $63 |
| Exemestane | 12 | $1,024 | $85 |
| Potassium Chloride | 16 | $687 | $43 |
| Gabapentin | 26 | $493 | $19 |
| Prednisone | 18 | $322 | $18 |
| Allopurinol | 35 | $313 | $9 |
| Ondansetron | 32 | $310 | $10 |
| Famotidine | 28 | $285 | $10 |
| Furosemide | 21 | $236 | $11 |
| Losartan | 12 | $126 | $11 |
| Levofloxacin | 12 | $125 | $10 |
| Pantoprazole | 11 | $99 | $9 |
2021: 18 drugs
| Revlimid | 53 | $900,631 | $16,993 |
| Venclexta | 29 | $378,035 | $13,036 |
| Jakafi | 19 | $256,490 | $13,499 |
| Ninlaro | 20 | $223,273 | $11,164 |
| Imbruvica | 18 | $213,322 | $11,851 |
| Xarelto | 13 | $14,519 | $1,117 |
| Entecavir | 16 | $10,563 | $660 |
| Anastrozole | 123 | $3,033 | $25 |
| Hydroxyurea | 46 | $2,789 | $61 |
| Acyclovir | 35 | $1,868 | $53 |
| Exemestane | 15 | $1,357 | $90 |
| Dexamethasone | 16 | $1,271 | $79 |
| Gabapentin | 20 | $709 | $35 |
| Prednisone | 22 | $323 | $15 |
| Ondansetron | 31 | $305 | $10 |
| Furosemide | 21 | $237 | $11 |
| Famotidine | 29 | $237 | $8 |
| Allopurinol | 21 | $196 | $9 |
2020: 19 drugs
| Revlimid | 25 | $427,752 | $17,110 |
| Venclexta | 30 | $346,004 | $11,533 |
| Ibrance | 16 | $201,667 | $12,604 |
| Jakafi | 12 | $178,758 | $14,896 |
| Imbruvica | 16 | $172,710 | $10,794 |
| Sprycel | 11 | $44,504 | $4,046 |
| Xarelto | 14 | $14,951 | $1,068 |
| Exemestane | 26 | $7,366 | $283 |
| Anastrozole | 118 | $2,928 | $25 |
| Hydroxyurea | 38 | $2,631 | $69 |
| Entecavir | 18 | $1,444 | $80 |
| Acyclovir | 15 | $927 | $62 |
| Dexamethasone | 11 | $888 | $81 |
| Tamoxifen Citrate | 14 | $742 | $53 |
| Gabapentin | 19 | $492 | $26 |
| Hydrocodone-Acetaminophen | 11 | $228 | $21 |
| Ondansetron | 17 | $166 | $10 |
| Allopurinol | 14 | $147 | $11 |
| Furosemide | 13 | $132 | $10 |
2019: 20 drugs
| Ibrance | 31 | $399,929 | $12,901 |
| Revlimid | 14 | $199,156 | $14,225 |
| Imbruvica | 17 | $177,400 | $10,435 |
| Jakafi | 11 | $151,099 | $13,736 |
| Xarelto | 11 | $8,991 | $817 |
| Exemestane | 25 | $7,806 | $312 |
| Hydroxyurea | 35 | $2,376 | $68 |
| Anastrozole | 93 | $2,208 | $24 |
| Dexamethasone | 25 | $1,652 | $66 |
| Acyclovir | 26 | $978 | $38 |
| Tamoxifen Citrate | 20 | $815 | $41 |
| Morphine Sulfate Er | 17 | $415 | $24 |
| Hydrocodone-Acetaminophen | 24 | $384 | $16 |
| Ondansetron | 27 | $281 | $10 |
| Prednisone | 13 | $271 | $21 |
| Gabapentin | 11 | $256 | $23 |
| Letrozole | 11 | $242 | $22 |
| Furosemide | 16 | $207 | $13 |
| Allopurinol | 11 | $205 | $19 |
| Lorazepam | 16 | $113 | $7 |
2018: 16 drugs
| Pomalyst | 25 | $431,014 | $17,241 |
| Imbruvica | 19 | $212,686 | $11,194 |
| Revlimid | 14 | $183,041 | $13,074 |
| Jakafi | 14 | $175,279 | $12,520 |
| Exemestane | 40 | $12,108 | $303 |
| Anastrozole | 107 | $2,859 | $27 |
| Hydroxyurea | 28 | $2,334 | $83 |
| Dexamethasone | 12 | $1,055 | $88 |
| Tamoxifen Citrate | 20 | $986 | $49 |
| Acyclovir | 22 | $873 | $40 |
| Gabapentin | 20 | $608 | $30 |
| Prednisone | 16 | $450 | $28 |
| Ondansetron | 29 | $361 | $12 |
| Hydrocodone-Acetaminophen | 24 | $341 | $14 |
| Furosemide | 12 | $142 | $12 |
| Lorazepam | 11 | $76 | $7 |
2017: 13 drugs
| Revlimid | 54 | $733,059 | $13,575 |
| Imbruvica | 13 | $145,358 | $11,181 |
| Exemestane | 41 | $14,220 | $347 |
| Anastrozole | 119 | $3,385 | $28 |
| Hydroxyurea | 29 | $3,133 | $108 |
| Tamoxifen Citrate | 15 | $791 | $53 |
| Acyclovir | 13 | $521 | $40 |
| Prednisone | 15 | $397 | $26 |
| Ondansetron | 17 | $263 | $15 |
| Hydrocodone-Acetaminophen | 12 | $259 | $22 |
| Mirtazapine | 13 | $252 | $19 |
| Omeprazole | 11 | $177 | $16 |
| Lorazepam | 20 | $173 | $9 |
2016: 13 drugs
| Revlimid | 48 | $596,609 | $12,429 |
| Exemestane | 17 | $5,029 | $296 |
| Anastrozole | 105 | $3,482 | $33 |
| Pradaxa | 12 | $1,781 | $148 |
| Hydrocodone-Acetaminophen | 33 | $1,616 | $49 |
| Morphine Sulfate Er | 34 | $1,424 | $42 |
| Gabapentin | 22 | $1,180 | $54 |
| Acyclovir | 22 | $1,006 | $46 |
| Tamoxifen Citrate | 13 | $732 | $56 |
| Ondansetron | 17 | $517 | $30 |
| Pantoprazole | 13 | $405 | $31 |
| Mirtazapine | 15 | $350 | $23 |
| Lorazepam | 12 | $105 | $9 |
2015: 12 drugs
| Dronabinol | 17 | $3,903 | $230 |
| Anastrozole | 54 | $1,186 | $22 |
| Morphine Sulfate Er | 23 | $1,164 | $51 |
| Hydrocodone-Acetaminophen | 15 | $603 | $40 |
| Acyclovir | 17 | $546 | $32 |
| Gabapentin | 11 | $514 | $47 |
| Omeprazole | 16 | $341 | $21 |
| Morphine Sulfate | 11 | $327 | $30 |
| Lorazepam | 31 | $296 | $10 |
| Mirtazapine | 20 | $284 | $14 |
| Prochlorperazine Maleate | 22 | $246 | $11 |
| Ondansetron | 14 | $208 | $15 |
2014: 19 drugs
| Revlimid | 52 | $404,550 | $7,780 |
| Neulasta | 19 | $81,805 | $4,306 |
| Exemestane | 12 | $5,106 | $426 |
| Morphine Sulfate Er | 12 | $2,113 | $176 |
| Anastrozole | 74 | $1,997 | $27 |
| Acyclovir | 38 | $796 | $21 |
| Ondansetron | 22 | $639 | $29 |
| Rabeprazole | 12 | $593 | $49 |
| Hydrocodone-Acetaminophen | 31 | $477 | $15 |
| Hydroxyurea | 11 | $469 | $43 |
| Omeprazole | 37 | $456 | $12 |
| Dexamethasone | 37 | $391 | $11 |
| Gabapentin | 16 | $269 | $17 |
| Lorazepam | 28 | $151 | $5 |
| Letrozole | 12 | $108 | $9 |
| Sertraline | 13 | $88 | $7 |
| Furosemide | 15 | $50 | $3 |
| Prednisone | 11 | $48 | $4 |
| Zolpidem | 11 | $38 | $3 |
2013: 18 drugs
| Revlimid | 28 | $285,740 | $10,205 |
| Sprycel | 15 | $107,043 | $7,136 |
| Nexium | 12 | $2,834 | $236 |
| Anastrozole | 68 | $2,442 | $36 |
| Ondansetron | 21 | $1,080 | $51 |
| Acyclovir | 24 | $1,058 | $44 |
| Hydroxyurea | 31 | $881 | $28 |
| Morphine Sulfate Er | 13 | $800 | $62 |
| Potassium Chloride | 17 | $426 | $25 |
| Dexamethasone | 18 | $203 | $11 |
| Hydrocodone-Acetaminophen | 14 | $173 | $12 |
| Enalapril-Hydrochlorothiazide | 12 | $107 | $9 |
| Paroxetine | 11 | $102 | $9 |
| Furosemide | 13 | $94 | $7 |
| Alprazolam | 13 | $93 | $7 |
| Lorazepam | 12 | $74 | $6 |
| Amlodipine Besylate | 13 | $63 | $5 |
| Atenolol | 11 | $39 | $4 |
Professional record
- NPI
- 1275591596
- Licence
- CA A92209California A92209: Current · expires 2026-12-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X)
- Mailing address
- 4501 X St, Suite 3016, Sacramento, CA, 95817
- NPI first listed
- 2006-05-03
- NPI last updated
- 2022-01-10
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.